Search - tctmd.com

Displaying 181 - 191 of 191

Sort: Relevancy | Date

Presentation ISET 2012

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

Presenter: Ron Waksman

January 15, 2012

News Industry News

Bard Acquires Lutonix, Inc.

December 19, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

November 03, 2011

News Daily News

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

Jason Kahn

September 15, 2011

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

News Industry News

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

July 25, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

Advertisement

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

Bard Acquires Lutonix, Inc.

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

Paclitaxel Balloon Maintains Advantage at 5 Years

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content